Phase
Condition
Lung Disease
Pleural Effusion
Treatment
N/AClinical Study ID
Ages 18-70 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients with cirrhotic liver and recurrent pleural effusion.
Pleural fluid should be transudate according to Light's criteria:
Pleural fluid-to-serum protein ratio less than 0.5
Pleural fluid lactic dehydrogenase (LDH) less than 200 IU
Pleural fluid-to-serum LDH ratio and pleural fluid-to-high normal serum LDH ratioless than 0.6
Exclusion
Exclusion Criteria:
Diagnosis of hepatocellular carcinoma or other neoplasm able to shorten lifeexpectancy.
Congestive heart failure.
Recent (i.e. within the previous 2 weeks) episode of digestive hemorrhage.
Exudative pleural effusion.
Ascitic fluid or pleural fluid infection
Platelet count below 50,000
Prothrombin activity below 50%
Study Design
Study Description
Connect with a study center
Tanta university hospital
Tanta,
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.